The Valley Desk

NCT04416568 · Interventional trial

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Overall registry status Active not recruiting

Phase 2

Conditions Atypical Teratoid/Rhabdoid Tumor, Chordoma (Poorly Differentiated or De-differentiated), Epithelioid Sarcoma, Malignant Rhabdoid Tumor, Other INI1 Negative Tumors (With PI Approval), Other SMARCA4-deficient Malignant Tumors (With PI Approval), Rhabdoid Tumor of the Kidney

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov